BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15589965)

  • 1. Extracellular signal-regulated kinase1/2 in contraction of vascular smooth muscle.
    Tsai MH; Jiang MJ
    Life Sci; 2005 Jan; 76(8):877-88. PubMed ID: 15589965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane a(2) induces differentiation of human mesenchymal stem cells to smooth muscle-like cells.
    Kim MR; Jeon ES; Kim YM; Lee JS; Kim JH
    Stem Cells; 2009 Jan; 27(1):191-9. PubMed ID: 18845763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
    Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
    Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery.
    Kawasaki J; Kobayashi S; Miyagi Y; Nishimura J; Fujishima M; Kanaide H
    Br J Pharmacol; 1997 Jul; 121(5):977-85. PubMed ID: 9222556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
    Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
    Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for Rho kinase in vascular contraction evoked by sodium fluoride.
    Jeon SB; Jin F; Kim JI; Kim SH; Suk K; Chae SC; Jun JE; Park WH; Kim IK
    Biochem Biophys Res Commun; 2006 Apr; 343(1):27-33. PubMed ID: 16527249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction.
    Tsai MH; Jiang MJ
    Pflugers Arch; 2006 Nov; 453(2):223-32. PubMed ID: 16953424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the Ca(2+)-sensitivity in phasic and tonic smooth muscle.
    Himpens B
    Verh K Acad Geneeskd Belg; 1992; 54(3):217-51. PubMed ID: 1413985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-associated kinase plays a role in rabbit urethral smooth muscle contraction, but not via enhanced myosin light chain phosphorylation.
    Walsh MP; Thornbury K; Cole WC; Sergeant G; Hollywood M; McHale N
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F73-85. PubMed ID: 20861082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hindlimb unweighting induces changes in the RhoA-Rho-kinase pathway of the rat abdominal aorta.
    Summers SM; Nguyen SV; Purdy RE
    Vascul Pharmacol; 2008; 48(4-6):208-14. PubMed ID: 18457998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane A2 stimulated signal transduction in vascular smooth muscle.
    Dorn GW; Becker MW
    J Pharmacol Exp Ther; 1993 Apr; 265(1):447-56. PubMed ID: 8474027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brazilein-induced contraction of rat arterial smooth muscle involves activation of Ca2+ entry and ROK, ERK pathways.
    Shen J; Yip S; Wang Z; Wang W; Xing D; Du L
    Eur J Pharmacol; 2008 Feb; 580(3):366-71. PubMed ID: 18177858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-kinase inhibitor inhibits both myosin phosphorylation-dependent and -independent enhancement of myofilament Ca2+ sensitivity in the bovine middle cerebral artery.
    Maeda Y; Hirano K; Nishimura J; Sasaki T; Kanaide H
    Br J Pharmacol; 2003 Nov; 140(5):871-80. PubMed ID: 14530221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C activation during Ca2+-independent vascular smooth muscle contraction.
    Throckmorton DC; Packer CS; Brophy CM
    J Surg Res; 1998 Jul; 78(1):48-53. PubMed ID: 9733617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms.
    Strittmatter F; Gratzke C; Weinhold P; Steib CJ; Hartmann AC; Schlenker B; Andersson KE; Hedlund P; Stief CG; Hennenberg M
    Eur J Pharmacol; 2011 Jan; 650(2-3):650-5. PubMed ID: 21044618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 3',4'-dihydroxyflavonol on vascular contractions of rat aortic rings.
    Song MJ; Baek I; Seo M; Kim SH; Suk K; Woodman OL; Williams SJ; Kim IK
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):803-10. PubMed ID: 20374259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).
    Sauro MD; Thomas B
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of long-term hypoxia on tension and intracellular calcium responses following stimulation of the thromboxane A(2) receptor in the left anterior descending coronary artery of fetal sheep.
    Maruko K; Stiffel VM; Gilbert RD
    Reprod Sci; 2009 Apr; 16(4):364-72. PubMed ID: 19336695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery.
    Choi SK; Ahn DS; Lee YH
    Cardiovasc Res; 2009 May; 82(2):324-32. PubMed ID: 19218288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal maturational shift from PKCzeta and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstriction.
    Cogolludo A; Moreno L; Lodi F; Tamargo J; Perez-Vizcaino F
    Cardiovasc Res; 2005 Apr; 66(1):84-93. PubMed ID: 15769451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.